Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Thiogenesis Therapeutics Corp V.TTI

Alternate Symbol(s):  TTIPF

Thiogenesis Therapeutics, Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing thiol-active therapeutic compounds, which are prodrugs used to treat unmet pediatric medical needs. The Company’s lead compound, TTI-0102, is a disulfide, made up of two thiols that lead to two independent cysteamine molecules. Cysteamine is a thiol that has been... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:TTI)

Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS

Newsfile March 25, 2024

Thiogenesis Announces Closing of Final Tranche in $4.5 Million Non-Brokered Private Placement

Newsfile December 20, 2023

Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation

Newsfile December 18, 2023

Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium

Newsfile December 4, 2023

Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board

Newsfile November 27, 2023

Thiogenesis Announces Non-Brokered Private Placement of Common Shares

Newsfile November 20, 2023

Thiogenesis Therapeutics Reports on Full Year 2022 Financial Results and Provides Corporate Update

Newsfile May 10, 2023

Thiogenesis Therapeutics (TSXV:TTI) grants stock options

Azuka Onwuka December 9, 2022

Thiogenesis Announces Stock Option Grants

Newsfile December 9, 2022
View More News ››

Opinion & Analysis (TSXV:TTI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:TTI)

RE:RE:RE:RE:listing today

H1..
Bassenon123 - April 22, 2022

RE:RE:RE:listing today

Complete in H1 or Q1?
GoodAtCharts - April 20, 2022

RE:RE:listing today

Waiting to hear the results of the PK study in Australia (dosage in 12 volunteers) which is expected to complete in H1 2022
Bassenon123 - April 20, 2022

RE:listing today

I have some shares of this company any thoughts? Target prices?
GoodAtCharts - April 19, 2022

listing today

finally....live today...if all goes well
Bassenon123 - April 13, 2022
View more Bullboard ››

i3 Energy Plc.

i3 Energy Plc.

i3 Energy is an oil and gas Company with a low cost, diversified, growing production base in Canada's most prolific ...
View More »